These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2598769)

  • 1. Effect of different doses of ursodeoxycholic acid in chronic liver disease.
    Podda M; Ghezzi C; Battezzati PM; Bertolini E; Crosignani A; Petroni ML; Zuin M
    Dig Dis Sci; 1989 Dec; 34(12 Suppl):59S-65S. PubMed ID: 2598769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ursodeoxycholic acid for chronic liver diseases.
    Podda M; Ghezzi C; Battezzati PM; Bertolini E; Crosignani A; Petroni ML; Zuin M
    J Clin Gastroenterol; 1988; 10 Suppl 2():S25-31. PubMed ID: 3062082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fenofibrate Improves Liver Function and Reduces the Toxicity of the Bile Acid Pool in Patients With Primary Biliary Cholangitis and Primary Sclerosing Cholangitis Who Are Partial Responders to Ursodiol.
    Ghonem NS; Auclair AM; Hemme CL; Gallucci GM; de la Rosa Rodriguez R; Boyer JL; Assis DN
    Clin Pharmacol Ther; 2020 Dec; 108(6):1213-1223. PubMed ID: 32480421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis.
    Combes B; Carithers RL; Maddrey WC; Lin D; McDonald MF; Wheeler DE; Eigenbrodt EH; Muñoz SJ; Rubin R; Garcia-Tsao G
    Hepatology; 1995 Sep; 22(3):759-66. PubMed ID: 7657280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjunct Fenofibrate Up-regulates Bile Acid Glucuronidation and Improves Treatment Response For Patients With Cholestasis.
    Gallucci GM; Trottier J; Hemme C; Assis DN; Boyer JL; Barbier O; Ghonem NS
    Hepatol Commun; 2021 Dec; 5(12):2035-2051. PubMed ID: 34558841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single or multiple dose ursodeoxycholic acid for cholestatic liver disease: biliary enrichment and biochemical response.
    van de Meeberg PC; Wolfhagen FH; Van Berge-Henegouwen GP; Salemans JM; Tangerman A; van Buuren HR; van Hattum J; van Erpecum KJ
    J Hepatol; 1996 Dec; 25(6):887-94. PubMed ID: 9007717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group.
    Poupon RE; Balkau B; Eschwège E; Poupon R
    N Engl J Med; 1991 May; 324(22):1548-54. PubMed ID: 1674105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of biliary enzyme levels and itching as a result of long-term administration of ursodeoxycholic acid in primary biliary cirrhosis.
    Matsuzaki Y; Tanaka N; Osuga T; Aikawa T; Shoda J; Doi M; Nakano M
    Am J Gastroenterol; 1990 Jan; 85(1):15-23. PubMed ID: 1967512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of ursodeoxycholic acid administration on biliary lipid secretion in primary biliary cirrhosis.
    Roda E; Mazzella G; Bazzoli F; Villanova N; Minutello A; Simoni P; Ronchi M; Poggi C; Festi D; Aldini R
    Dig Dis Sci; 1989 Dec; 34(12 Suppl):52S-58S. PubMed ID: 2598768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ursodeoxycholic acid in chronic hepatitis and primary biliary cirrhosis.
    Osuga T; Tanaka N; Matsuzaki Y; Aikawa T
    Dig Dis Sci; 1989 Dec; 34(12 Suppl):49S-51S. PubMed ID: 2574657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group.
    Lindor KD
    N Engl J Med; 1997 Mar; 336(10):691-5. PubMed ID: 9041099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ursodeoxycholic therapy in chronic liver disease: a meta-analysis in primary biliary cirrhosis and in chronic hepatitis.
    Simko V; Michael S; Prego V
    Am J Gastroenterol; 1994 Mar; 89(3):392-8. PubMed ID: 8122652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of chronic active hepatitis and primary biliary cirrhosis with ursodeoxycholic acid.
    Güldütuna S; Leuschner U; Imhof M; Zimmer G
    Z Gastroenterol; 1992 Mar; 30 Suppl 1():49-54. PubMed ID: 1449017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ursodeoxycholic acid on the kinetics of the major hydrophobic bile acids in health and in chronic cholestatic liver disease.
    Beuers U; Spengler U; Zwiebel FM; Pauletzki J; Fischer S; Paumgartner G
    Hepatology; 1992 Apr; 15(4):603-8. PubMed ID: 1551637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of cholestatic liver diseases with ursodeoxycholic acid].
    Boberg KM; Schrumpf E
    Tidsskr Nor Laegeforen; 1997 Sep; 117(23):3370-3. PubMed ID: 9411890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ursodeoxycholic acid and taurine on serum liver enzymes and bile acids in chronic hepatitis.
    Podda M; Ghezzi C; Battezzati PM; Crosignani A; Zuin M; Roda A
    Gastroenterology; 1990 Apr; 98(4):1044-50. PubMed ID: 1968871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved liver tests and greater biliary enrichment with high dose ursodeoxycholic acid in early stage primary biliary cirrhosis.
    Roda E; Azzaroli F; Nigro G; Piazza F; Jaboli F; Ferrara F; Liva S; Giovanelli S; Miracolo A; Colecchia A; Festi D; Mazzeo C; Bacchi L; Roda A; Mazzella G
    Dig Liver Dis; 2002 Jul; 34(7):523-7. PubMed ID: 12236487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of cholestatic liver disease].
    Pleşa A
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(4):733-6. PubMed ID: 14756010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ursodeoxycholic acid--a new therapy concept in cholestatic liver diseases].
    Raedsch R; Stiehl A
    Klin Wochenschr; 1989 Feb; 67(4):265-8. PubMed ID: 2648062
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of cholestatic disease in 2017.
    de Vries E; Beuers U
    Liver Int; 2017 Jan; 37 Suppl 1():123-129. PubMed ID: 28052628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.